BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30770248)

  • 1. Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8
    Zhang F; Li R; Yang Y; Shi C; Shen Y; Lu C; Chen Y; Zhou W; Lin A; Yu L; Zhang W; Xue Z; Wang J; Cai Z
    Immunity; 2019 Mar; 50(3):738-750.e7. PubMed ID: 30770248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia preconditioned renal tubular epithelial cell-derived extracellular vesicles alleviate renal ischaemia-reperfusion injury mediated by the HIF-1α/Rab22 pathway and potentially affected by microRNAs.
    Zhang L; Liu H; Xu K; Ling Z; Huang Y; Hu Q; Lu K; Liu C; Wang Y; Liu N; Zhang X; Xu B; Wu J; Chen S; Zhang G; Chen M
    Int J Biol Sci; 2019; 15(6):1161-1176. PubMed ID: 31223277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrite-derived nitric oxide reduces hypoxia-inducible factor 1α-mediated extracellular vesicle production by endothelial cells.
    Burnley-Hall N; Willis G; Davis J; Rees DA; James PE
    Nitric Oxide; 2017 Feb; 63():1-12. PubMed ID: 28017872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia/reperfusion injury.
    Yang MQ; Du Q; Goswami J; Varley PR; Chen B; Wang RH; Morelli AE; Stolz DB; Billiar TR; Li J; Geller DA
    Hepatology; 2018 Mar; 67(3):1056-1070. PubMed ID: 29059701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-derived extracellular vesicles regulate B-cell IgG production
    Yang J; Dang G; Lü S; Liu H; Ma X; Han L; Deng J; Miao Y; Li X; Shao F; Jiang C; Xu Q; Wang X; Feng J
    FASEB J; 2019 Nov; 33(11):12780-12799. PubMed ID: 31480861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles from
    Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
    Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
    Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
    J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Hypoxia-Inducible Factor Expression in CD8
    Veliça P; Cunha PP; Vojnovic N; Foskolou IP; Bargiela D; Gojkovic M; Rundqvist H; Johnson RS
    Cancer Immunol Res; 2021 Apr; 9(4):401-414. PubMed ID: 33602720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
    Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.
    Zah E; Lin MY; Silva-Benedict A; Jensen MC; Chen YY
    Cancer Immunol Res; 2016 Jun; 4(6):498-508. PubMed ID: 27059623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting high-grade B cell lymphoma with CD19-specific T cells.
    Lehmann FM; Maurberger A; Feicht S; Helm F; Ladinig C; Kieback E; Uckert W; Kammertöns T; Kremmer E; Mautner J; Gerbitz A; Bornkamm GW
    Int J Cancer; 2014 Sep; 135(5):1153-64. PubMed ID: 24500882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.
    Hammami A; Charpentier T; Smans M; Stäger S
    PLoS Pathog; 2015 Jun; 11(6):e1004938. PubMed ID: 26046638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 3D heterotypic spheroid model for studying extracellular vesicle-mediated tumour and immune cell communication.
    Sadovska L; Zandberga E; Sagini K; Jēkabsons K; Riekstiņa U; Kalniņa Z; Llorente A; Linē A
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1930-1935. PubMed ID: 29248729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J; Martinson JA; Klingemann HG
    Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Kitanaka A; Imai C; Bhattacharyya J; Kubo T; Takei Y; Yasunaga S; Takihara Y; Kimura A
    Br J Haematol; 2010 Oct; 151(1):37-46. PubMed ID: 20678160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses.
    Demarta-Gatsi C; Rivkin A; Di Bartolo V; Peronet R; Ding S; Commere PH; Guillonneau F; Bellalou J; Brûlé S; Abou Karam P; Cohen SR; Lagache T; Janse CJ; Regev-Rudzki N; Mécheri S
    Cell Microbiol; 2019 Jul; 21(7):e13021. PubMed ID: 30835870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
    Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.